---
phase: 05-cluster-neuromotor
verified: 2026-03-13T18:00:00Z
status: passed
score: 10/10 must-haves verified
gaps: []
human_verification:
  - test: "Review clinical content accuracy of 10 Kleim & Jones neuroplasticity principles applied per phase"
    expected: "Each phase (Sections 5, 6, 7) names the correct subset of principles with coherent neurobiological rationale"
    why_human: "Requires domain knowledge to confirm correct mapping of principles to phase goals — structural presence verified, clinical accuracy requires clinician review"
  - test: "Review levodopa timing evidence basis in P-06"
    expected: "45–60 min post-dose rule is correctly grounded in PMC11307027 and pharmacokinetic rationale for levodopa peak-plasma timing"
    why_human: "Pharmacological accuracy of timing window requires clinician/pharmacist review"
  - test: "Review pictographic HEP policy specifications in P-18"
    expected: "Format specifications (image + frequency symbol, no text for MMSE < 24) are clinically implementable as described"
    why_human: "Practical usability of pictographic HEP design requires OT/PT review of real-world implementation"
---

# Phase 5: Cluster Neuromotor — Verification Report

**Phase Goal:** P-03 AVC, P-06 Parkinson, and P-18 Demência are complete protocols, delivering the neuromotor cluster including dual-task training sub-category template and cognitively-adapted instruction approach — drafted in sequence (P-03 first, then P-06, then P-18) to respect neuroplasticity knowledge dependencies within the cluster.
**Verified:** 2026-03-13T18:00:00Z
**Status:** passed
**Re-verification:** No — initial verification

---

## Goal Achievement

### Observable Truths

| # | Truth | Status | Evidence |
|---|-------|--------|----------|
| 1 | P-03 covers exclusively chronic-phase stroke (> 6 months) with explicit temporal scope declaration excluding acute/subacute AVC | VERIFIED | Line 16: "DELIMITAÇÃO TEMPORAL OBRIGATÓRIA" block; line 50: NÃO COBRE block with explicit redirections; line 6: frontmatter declares "FASE CRÔNICA (> 6 meses do evento)" |
| 2 | P-03 includes neuroplasticity-grounded phase progression with Kleim & Jones 10 principles (PMID 18230848) as formal theoretical foundation | VERIFIED | Section 4.2 dedicated to 10 principles; each phase section (5, 6, 7) names active principles with rationale; PMID 18230848 cited at lines 242, 626, 1021, 1129 |
| 3 | P-03 includes aphasia/apraxia instruction adaptation subsection with physical demonstration as primary mode, hand-over-hand, visual feedback, and single-keyword verbal reduction | VERIFIED | Section 5.3 "Subsistema de Adaptação de Instrução — Afasia e Apraxia" at line 317; 5-mode instruction hierarchy (demo → hand-over-hand → visual feedback → keyword → full verbal); 4 patient profiles (A–D) |
| 4 | P-03 creates TEMPLATE CLUSTER NEUROMOTOR for dual-task training in Phase 3 with entry criteria (BBS-BR >= 40 + TUG < 20) and 4-level progressive difficulty table (DT-1 to DT-4) — named and referenceable | VERIFIED | Section 7.2 at line 630: "TEMPLATE CLUSTER NEUROMOTOR — Treinamento de Dupla Tarefa"; entry criteria at lines 653–654 (BBS-BR >= 40, TUG < 20); 4-level table at lines 667–670 (DT-1 through DT-4); explicit note that P-06 and P-18 reference by name |
| 5 | P-03 populates Section 13 by cross-reference to P-04 Seção 5.2, P-08 Seção 6.3, and P-07 Seções 5.2/7.2 — never re-deriving shared knowledge | VERIFIED | Section 13 at lines 956–959: explicit table with P-07 Seção 5.2, P-07 Seção 7.2, P-08 Seção 6.3, P-04 Seção 5.2 listed with activation triggers and anti-pattern warning |
| 6 | P-03 Section 8 includes PAINAD-BR (PubMed 25993063) as primary pain instrument when severe aphasia makes NRS unreliable | VERIFIED | Section 8.2 at line 771: "PAINAD-BR é o instrumento PRIMÁRIO"; PubMed 25993063 cited at lines 775, 1023, 1139; 5-domain table and action thresholds (0–2 continue, 3–5 reduce 25%, >= 6 suspend) at lines 797–801 |
| 7 | P-06 specifies levodopa timing rule: all sessions 45–60 min post-dose in 'on' state, with explicit 'off' state alternative session policy (reduce load 30%, seated exercises, no balance hierarchy progression) | VERIFIED | Line 16: rule declared as OBRIGATÓRIA in frontmatter block; line 58 repeats rule; off-state alternative protocol at lines 225–238: 9-step procedure, 30% load reduction, no progression, no DT |
| 8 | P-06 includes formal caregiver training as protocol component (not optional) with minimum 3 sessions across phases and defined content per APTA CPG 2022 | VERIFIED | 3 formal sessions at Sections 5.9 (30 min Phase 1), 6.7 (45 min Phase 2), 7.7 (30 min Phase 3); APTA CPG 2022 PMC9046970 cited at line 333 as basis; content includes on/off recognition, cueing for freezing, support positioning, home safety |
| 9 | P-18 uses procedural/implicit learning instruction design with MMSE-BR stratified instruction complexity table (>= 24, 20–23, < 24, < 18) | VERIFIED | Section 5.3 "Sistema de Instrução Adaptada ao Nível Cognitivo" at line 201; 4-stratum table at lines 209–212; Kalbe 2007 as pedagogical foundation cited at lines 14, 23, 148, 203; 6 procedural instruction techniques listed |
| 10 | P-18 integrates PAINAD-BR as primary pain instrument for MMSE < 18; caregiver involvement as structural component; MMSE-BR/MoCA-BR mandated at baseline; P-03 dual-task template referenced without re-derivation; Abbey Pain Scale low confidence noted; both P-06 and P-18 answer all 8 clinical validity questions | VERIFIED | PAINAD-BR primary at Section 8.1 line 549; caregiver as inclusion criterion at lines 19, 71; MMSE-BR/MoCA-BR mandatory at lines 109–110; P-03 Section 7.2 referenced at line 445; Abbey Pain Scale low confidence note at Section 8.3 line 591 and Question section line 894; Section 15 with 8 questions at line 823 for P-18; Section 15 at line 776 for P-06 |

**Score:** 10/10 truths verified

---

### Required Artifacts

| Artifact | Expected | Status | Details |
|----------|----------|--------|---------|
| `protocols/P-03-AVC.md` | Complete chronic stroke rehabilitation protocol with neuroplasticity foundation and dual-task template | VERIFIED | 1147 lines, 15 sections, Brazilian Portuguese; contains "neuroplasticidade" throughout; commits bccfa72 |
| `protocols/P-06-PARKINSON.md` | Complete Parkinson disease rehabilitation protocol with levodopa timing and caregiver training | VERIFIED | 850 lines, 15 sections, Brazilian Portuguese; contains "levodopa" as structural rule; commit 56fa323 |
| `protocols/P-18-DEMENCIA.md` | Complete dementia rehabilitation protocol with cognitive-adapted instruction system | VERIFIED | 902 lines, 15 sections, Brazilian Portuguese; contains "aprendizagem procedimental" as pedagogical foundation; commit 56fa323 |
| `protocols/SHARED-FOUNDATION.md` | P-03, P-06, and P-18 rows in cross-reference index (Section 8.1) | VERIFIED | Three complete rows at lines 557, 560, 572 respectively; P-03 row has 9 interactions, P-06 row has 9 interactions, P-18 row has 9 interactions; commits a8cc0c1, 3d5ae2a |

---

### Key Link Verification

| From | To | Via | Status | Details |
|------|----|-----|--------|---------|
| P-03-AVC.md Section 5/6/7 | Kleim JA Jones TA 2008 PMID 18230848 | Neuroplasticity principles applied to phase progression | WIRED | PMID 18230848 cited 4+ times; Section 4.2 dedicated to 10 principles; each phase section names active principles |
| P-03-AVC.md Phase 3 (Section 7.2) | TEMPLATE CLUSTER NEUROMOTOR with 4-level DT table | Dual-task template as named referenceable section | WIRED | "TEMPLATE CLUSTER NEUROMOTOR — Treinamento de Dupla Tarefa" created at Section 7.2; explicit instruction "NÃO RE-DERIVAR em P-06 ou P-18" |
| P-03-AVC.md Section 13 | P-07 Seção 5.2, P-07 Seção 7.2, P-08 Seção 6.3, P-04 Seção 5.2 | Cross-modifier chain | WIRED | All 4 cross-references present in Section 13 table with specific section numbers and activation triggers |
| P-06-PARKINSON.md Section 5 | Levodopa timing 45–60 min post-dose | Session scheduling rule | WIRED | Pattern "45–60 min" present at lines 16, 58, 70, 110, 123, 174; on/off state table at Section 5.2 |
| P-06-PARKINSON.md Phase 3 | P-03-AVC.md Section 7.2 | Dual-task template cross-reference with Parkinson adaptation | WIRED | "TEMPLATE CLUSTER NEUROMOTOR — P-03 Seção 7.2 com adaptações P-06" at line 20, 477, 493; Parkinson-specific adaptations (on state mandatory, off contraindicated) documented |
| P-06-PARKINSON.md | APTA CPG 2022 PMC9046970 | Primary guideline alignment | WIRED | PMC9046970 cited at lines 12, 147, 157, 333, 368, 743 |
| P-18-DEMENCIA.md Section 5/6/7 | Kalbe 2007 implicit/procedural learning | Pedagogical instruction design foundation | WIRED | "aprendizagem procedimental" present throughout; Kalbe 2007 cited at lines 14, 23, 141, 148, 203, 471, 785, 890 |
| P-18-DEMENCIA.md Section 8.1 | PAINAD-BR PubMed 25993063 | Primary pain instrument for MMSE < 18 | WIRED | PubMed 25993063 at lines 111, 549; Section 8.1 header explicitly states primary instrument; 5-domain table present |
| P-18-DEMENCIA.md Section 2 | MMSE-BR / MoCA-BR | Mandatory cognitive screening at baseline | WIRED | Both instruments declared MANDATORY at lines 109–110; MMSE-BR as "instrumento primário de estratificação" |
| P-18-DEMENCIA.md Phase 3 | P-03-AVC.md Section 7.2 | Dual-task template with dementia adaptation | WIRED | "TEMPLATE CLUSTER NEUROMOTOR conforme P-03 Seção 7.2" at line 447; dementia adaptations (FAMILIAR/PROCEDURAL tasks; NEVER arithmetic for MMSE < 20) at line 457 |
| SHARED-FOUNDATION.md Section 8.1 | P-03-AVC.md, P-06-PARKINSON.md, P-18-DEMENCIA.md | Cross-reference matrix rows | WIRED | All three rows present with 9+ comorbidity interactions, key features, scope notes, instruments, and safety alerts |

---

### Requirements Coverage

| Requirement | Source Plan | Description | Status | Evidence |
|-------------|------------|-------------|--------|----------|
| PROT-08 | 05-01-PLAN.md | P-03 AVC/AVE (fase crônica, neuroplasticidade) | SATISFIED | P-03-AVC.md exists at 1147 lines; chronic phase scope declared; neuroplasticity foundation (Kleim & Jones PMID 18230848) as Section 4.2; TEMPLATE CLUSTER NEUROMOTOR at Section 7.2; aphasia/apraxia subsystem at Section 5.3; PAINAD-BR at Section 8.2; all 15 sections present |
| PROT-09 | 05-02-PLAN.md | P-06 Doença de Parkinson | SATISFIED | P-06-PARKINSON.md exists at 850 lines; levodopa timing rule (45–60 min post-dose) declared as structural rule; on/off state differentiation table at Section 5.2 with 11 domains; formal caregiver training 3 sessions (Sections 5.9, 6.7, 7.7); APTA CPG 2022 (PMC9046970) as primary guideline; TEMPLATE CLUSTER NEUROMOTOR referenced at Section 7.2 with Parkinson adaptation |
| PROT-10 | 05-02-PLAN.md | P-18 Demência / Alzheimer (leve a moderado) | SATISFIED | P-18-DEMENCIA.md exists at 902 lines; MMSE-stratified instruction system (4 strata) at Section 5.3; Kalbe 2007 as pedagogical foundation; pictographic HEP policy at Section 7.3; PAINAD-BR primary for MMSE < 18 at Section 8.1; caregiver as inclusion criterion (line 71); Abbey Pain Scale low-confidence note at Section 8.3 and Question section |

**Orphaned requirements:** None. REQUIREMENTS.md maps exactly PROT-08, PROT-09, PROT-10 to Phase 5. All three are claimed by plans and verified. The "Pending" status shown in the REQUIREMENTS.md traceability table (lines 131–133) reflects a documentation update not yet applied — the actual protocols exist and are complete.

---

### Anti-Patterns Found

| File | Line | Pattern | Severity | Impact |
|------|------|---------|----------|--------|
| None found | — | — | — | — |

Scan performed on P-03-AVC.md, P-06-PARKINSON.md, P-18-DEMENCIA.md for: TODO/FIXME/PLACEHOLDER markers, empty implementations, stub sections, "not implemented" indicators. No anti-patterns detected. All protocol sections contain substantive clinical content.

---

### Commit Integrity

All four commits referenced in SUMMARY files verified present in the repository:

| Commit | Task | Content |
|--------|------|---------|
| bccfa72 | Plan 01 Task 1 | Create P-03-AVC.md (1147 lines) |
| a8cc0c1 | Plan 01 Task 2 | Update SHARED-FOUNDATION P-03 row |
| 56fa323 | Plan 02 Task 1 | Create P-06-PARKINSON.md (850 lines) + P-18-DEMENCIA.md (902 lines) |
| 3d5ae2a | Plan 02 Task 2 | Update SHARED-FOUNDATION P-06 and P-18 rows |

---

### Human Verification Required

#### 1. Kleim & Jones Principle Mapping Per Phase

**Test:** Review Sections 5, 6, and 7 of P-03-AVC.md against the 10 principles in Section 4.2 — confirm the principles assigned to each phase match the neurobiological rationale described.
**Expected:** Phase 1 activates "Use it or lose it," "Specificity," "Salience matters"; Phase 2 activates "Repetition matters," "Intensity matters," "Time matters," "Salience matters"; Phase 3 activates "Transference," "Interference," "Salience matters" — and the rationale in each phase section coherently supports that assignment.
**Why human:** Requires neuroscience domain expertise to confirm the mapping is clinically sound, not just structurally present.

#### 2. Levodopa Timing Evidence Basis

**Test:** Review the pharmacokinetic rationale for the 45–60 min post-dose window in P-06 Section 5.1 and PMC11307027 citation.
**Expected:** The timing window correctly reflects levodopa peak-plasma time, and the cited evidence supports both the neuroprotective rationale and the exercise-on-levodopa interaction as stated.
**Why human:** Pharmacological accuracy of the specific timing window requires clinician or pharmacist review against the cited reference.

#### 3. Pictographic HEP Policy Implementability

**Test:** Review the pictographic HEP specifications in P-18 Section 7.3 for clinical implementability.
**Expected:** The format specifications (image + exercise name in 3 words + frequency symbol only — no text — for MMSE < 24) are actually achievable with standard clinical resources and the caregiver training approach is realistic.
**Why human:** Practical usability and real-world implementability of the pictographic format requires OT/PT judgment about clinical resource availability.

---

### Phase Sequencing Verification

The phase goal required drafting in sequence P-03 first, then P-06, then P-18 to respect neuroplasticity knowledge dependencies.

- Plan 01 (`depends_on: []`) produced P-03, establishing the TEMPLATE CLUSTER NEUROMOTOR
- Plan 02 (`depends_on: ["05-01"]`) produced P-06 and P-18, both consuming the template by reference

Commit timestamps confirm: bccfa72 (P-03, 16:31:03) precedes 56fa323 (P-06 + P-18, 16:48:51) — sequence respected.

P-06 and P-18 both explicitly reference "P-03 Seção 7.2" for dual-task training without re-deriving the template. The anti-re-derivation contract is honored: both protocols state they apply the TEMPLATE with protocol-specific adaptations, directing the clinician to P-03 Section 7.2 for the full table.

---

### Gaps Summary

No gaps. All 10 observable truths verified, all 4 artifacts substantive and wired, all 11 key links confirmed present, all 3 requirements satisfied, no anti-patterns detected.

The neuromotor cluster is complete:
- P-03 establishes the neuroplasticity theoretical foundation, the dual-task template (TEMPLATE CLUSTER NEUROMOTOR), and the aphasia/apraxia instruction subsystem
- P-06 adds the levodopa pharmacological layer and formal caregiver training
- P-18 adds the MMSE-stratified cognitive instruction system and pictographic HEP policy
- SHARED-FOUNDATION Section 8.1 has all three protocol rows with 9+ interactions each

The only note is that REQUIREMENTS.md lines 131–133 still show "Pending" for PROT-08/09/10 — this is a documentation status field, not a protocol deficiency. The protocols themselves are complete and verified.

---

_Verified: 2026-03-13T18:00:00Z_
_Verifier: Claude (gsd-verifier)_
